Trastuzumab-Induced Interstitial Pneumonitis

Trastuzumab is a recombinant immunoglobulin G1 monoclonal antibody used to treat human epidermal growth factor receptor 2 (HER2) cancers. Trastuzumab-induced interstitial pneumonitis is a rare adverse effect reported in a few patients. Interstitial pneumonitis presents as symptoms of dyspnea, hypoxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Errisuriz, Kimberly, Bazan, Daniela Z, Verduzco Jr., Rene, Guedez, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436675/
https://www.ncbi.nlm.nih.gov/pubmed/37602136
http://dx.doi.org/10.7759/cureus.42116